# Progesterone and Second Trimester Bleeding

> **NCT01269450** · NA · TERMINATED · sponsor: **HaEmek Medical Center, Israel** · enrollment: 128 (actual)

## Conditions studied

- Antepartum Bleeding
- Preterm Birth

## Interventions

- **DRUG:** micronized progesterone 200 mg (Utrogestan)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01269450
- **Lead sponsor:** HaEmek Medical Center, Israel
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-03
- **Primary completion:** 2017-01
- **Final completion:** 2017-07
- **Target enrollment:** 128 (ACTUAL)
- **Why stopped:** Slow recruitment
- **Last updated:** 2018-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01269450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01269450, "Progesterone and Second Trimester Bleeding". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01269450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*